V-Bio Ventures portfolio company Orionis Biosciences announces collaboration with Genentech to discover and develop molecular glue class medicines
September 20, 2023, BOSTON, MA and GHENT, Belgium – [...]
September 20, 2023, BOSTON, MA and GHENT, Belgium – [...]
Funds to support further development and commercialisation of [...]
Andera Partners annonce avoir réuni un montant final de [...]
After guiding the company for more than four [...]
Siparex ETI 5 accroît ainsi fortement l’impact financier [...]
Expertum concludes a strategic partnership with Sofindev. The [...]
Stockholm, 11 September 2023 — Main Capital Partners (‘Main’) [...]
Brussels, 30 August 2023 - The Belgian Venture [...]
August 24th 2023, Stockholm – Main Capital Partners is [...]
Investeringsmaatschappij Standard Investment heeft onlangs een meerderheidsbelang verworven [...]